Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART) - Trial NCT06280820
Access comprehensive clinical trial information for NCT06280820 through Pure Global AI's free database. This phase not specified trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI) and is currently Not yet recruiting. The study focuses on Heart Failure. Target enrollment is 2000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
National Heart, Lung, and Blood Institute (NHLBI)
National Institutes of Health Clinical Center (CC)
Timeline & Enrollment
N/A
Apr 01, 2024
Apr 30, 2034
Primary Outcome
To study the association between multi-omics signatures with all-cause mortality
Summary
Background:
 
 More than 6.5 million people in the United States live with heart failure (HF), and more than
 a million new cases are diagnosed each year. Treatments have improved in recent years, but
 researchers want to understand more about how HF develops. To do this, they need to compare
 blood and other samples from many people with HF.
 
 Objective:
 
 To collect blood and other samples from people with HF. These samples will be used to
 identify and study proteins and other factors that may lead to decreased heart function over
 time.
 
 Eligibility:
 
 People aged 18 years and older with heart failure.
 
 Design:
 
 Participants will be asked to join the study based on a review of their medical records.
 
 They will have 1 study visit. They will provide a blood sample: About 3 tablespoons will be
 collected from a needle inserted into a vein.
 
 Other tests are optional: Participants may provide urine and stool samples. They may have a
 cotton swab rubbed on the inside of the mouth to collect DNA.
 
 Participants may also take 3 questionnaires. They will answer questions about dietary,
 social, and other factors that affect their health. Participants will receive compensation.
 
 Researchers will follow the participants health by monitoring their medical records for up to
 5 years.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06280820
Non-Device Trial